233 related articles for article (PubMed ID: 1361192)
1. Issues and advances in the pharmacotherapy of asthma.
Kelly HW
J Clin Pharm Ther; 1992 Oct; 17(5):271-81. PubMed ID: 1361192
[TBL] [Abstract][Full Text] [Related]
2. Asthma, inflammation, and airway hyperresponsiveness in children.
Murphy S; Kelly HW
Curr Opin Pediatr; 1993 Jun; 5(3):255-65. PubMed ID: 8104077
[TBL] [Abstract][Full Text] [Related]
3. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
Holimon TD; Chafin CC; Self TH
Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
[TBL] [Abstract][Full Text] [Related]
4. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
Bisgaard H
Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of childhood asthma. An inflammatory disease.
Van Bever HP; Stevens WJ
Drugs; 1992 Jul; 44(1):36-46. PubMed ID: 1379908
[TBL] [Abstract][Full Text] [Related]
6. The role of inflammation and anti-inflammatory medication in asthma.
Barnes PJ
Respir Med; 2002 Feb; 96 Suppl A():S9-15. PubMed ID: 11858564
[TBL] [Abstract][Full Text] [Related]
7. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
[TBL] [Abstract][Full Text] [Related]
8. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
[TBL] [Abstract][Full Text] [Related]
9. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
Naedele-Risha R; Dorinsky P; Craig TJ
J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.
Stoloff S; Poinsett-Holmes K; Dorinsky PM
Pharmacotherapy; 2002 Feb; 22(2):212-26. PubMed ID: 11837559
[TBL] [Abstract][Full Text] [Related]
11. Beclomethasone dipropionate attenuates airways hyperresponsiveness to neurokinin A and histamine in asthma.
Prosperini G; Arcidiacono G; Ciamarra I; Crimi N; Polosa R
Respir Med; 2006 Jun; 100(6):1006-12. PubMed ID: 16290928
[TBL] [Abstract][Full Text] [Related]
12. Monitoring asthma therapy using indirect bronchial provocation tests.
Brannan JD; Koskela H; Anderson SD
Clin Respir J; 2007 Jul; 1(1):3-15. PubMed ID: 20298272
[TBL] [Abstract][Full Text] [Related]
13. [Bronchodilator effect of salmeterol and inhibition of bronchial hyperreactivity].
Boulet LP
Rev Mal Respir; 1992; 9 Suppl 1():R11-3. PubMed ID: 1350363
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilators: new drugs and controversies.
Kleerup EC
Curr Opin Pulm Med; 1997 Jan; 3(1):17-22. PubMed ID: 9139768
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
16. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
Woolcock A; Lundback B; Ringdal N; Jacques LA
Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
[TBL] [Abstract][Full Text] [Related]
17. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
[TBL] [Abstract][Full Text] [Related]
19. New drugs for asthma.
Barnes PJ
Eur Respir J; 1992 Oct; 5(9):1126-36. PubMed ID: 1358672
[TBL] [Abstract][Full Text] [Related]
20. Beta-2 agonist discussions in asthma and a review of current data.
Erdinç M
Tuberk Toraks; 2011; 59(2):205-12. PubMed ID: 21740399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
